Remove Bioassay Remove Development Remove Genome Remove Protein
article thumbnail

Evaluating methods targeting Protein-Protein Interactions

pharmaphorum

Protein-protein interactions (PPIs) are becoming increasingly relevant in the pathology of many diseases, including cancer. The issue, however, is developing an effective way of targeting them. . PPIs are an integral part of the physiology of living organisms, as complexes which control biological pathways mediated by proteins.

Protein 126
article thumbnail

Can artificial intelligence help craft new medicines?

Drug Discovery World

The drug target for Penicillin is a protein that helps bacteria to synthesise its cell wall. The potential of drug targets Over the next 50 years, new targets emerged and drugs were developed against them. Here, new bioassay technologies helped testing, but more definite answers were required.

article thumbnail

Reimagining cell engineering with picodroplet microfluidic technology

Drug Discovery World

Cell engineering is bringing life science into a new era of biotherapeutic discovery and development, disease modelling, and synthetic biology research. Within picodroplets, single cells are assayed to identify specific proteins to find rare cells of interest or cells with high productivity.